indirubin has been researched along with Lung Neoplasms in 3 studies
*Lung Neoplasms: Tumors or cancer of the LUNG. [MeSH]
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chung, HJ; Hong, JY; Kim, YC; Lee, JW; Lee, SK; Min, HY; Moon, MJ; Park, EJ; Park, HJ | 1 |
Abdalsamad, MR; C Chandramoorthy, H; Dera, A; Rajagopalan, P | 1 |
Ji, XJ; Zhang, FR | 1 |
3 other study(ies) available for indirubin and Lung Neoplasms
Article | Year |
---|---|
Induction of apoptosis by a novel indirubin-5-nitro-3'-monoxime, a CDK inhibitor, in human lung cancer cells.
Topics: Antibiotics, Antineoplastic; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinases; Humans; Indoles; Interphase; Lung Neoplasms; Structure-Activity Relationship | 2005 |
Rational combinations of indirubin and arylidene derivatives exhibit synergism in human non-small cell lung carcinoma cells.
Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; bcl-2-Associated X Protein; Benzylidene Compounds; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Humans; Indans; Indoles; Lung Neoplasms; Neoplasm Metastasis; Oximes; Proto-Oncogene Proteins c-bcl-2 | 2019 |
[Studies on antineoplastic action of indirubin derivatives and analogs and their structure-activity relationships].
Topics: Animals; Antibiotics, Antineoplastic; Carcinoma 256, Walker; Indoles; Lung Neoplasms; Mice; Rats; Structure-Activity Relationship | 1985 |